Authors
Latest:
Integrated Pre-Formulation Studies for Fast Advancement of Drug Candidates to Human Clinical StudiesLooking for a fast pathway to an investigational new drug application (IND) for your new drug candidates? This webcast will discuss strategies to select the most developable molecules and quickly develop an IND-ready formulation within 8–12 weeks using real-world case studies. Live: Wednesday, April 15, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Apr. 15, 2021 Register free
Latest:
Booming Biotech: Five Start-Ups to Watch in CambridgeAccording to recent figures, Cambridge’s technology sector is booming and the city is emerging as a hub for biotech companies.
Latest:
Optimizing Equipment Availability for Capsule FillersLearn what the common equipment bottlenecks are and how engineering developments can maximize equipment availability. Experts will provide insight into how to minimize cycle, set-up, and changeover times and how to define optimal parameters for each process step. Live: Tuesday, Mar. 24, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET On demand available after airing until Mar. 24, 2021 Register free
Latest:
Determination of Related Substances in Pemetrexed Disodium (Form-IV) in Bulk Drug Samples by HPLCThe authors describe the development of a stability-indicating reverse-phase high-performance liquid chromatographic (RP?HPLC) method for the quantitative determination of potential genotoxic impurities present in pemetrexed disodium (form-IV). The chromatographic separation was achieved on a RP?HPLC column (Zorbax SB-Phenyl, Agilent) at ambient temperature with gradient elution using mobile phase A (trifluoroacetic acid [TFA] in water) and mobile phase B (TFA in acetonitrile).
Latest:
Global Considerations for Oligonucleotide Synthesis SolutionsWebinar Date/Time: Thu, Oct 24, 2024 10:00 AM EDT
Latest:
Leveraging Cygnus Technologies Quality with Fully Automated CHO HCP Assays on EllaSimple Plex™ Assays on Ella™ are hands-free, fast and reproducible immunoassays that eliminate all manual steps of traditional ELISAs. In this application note, we pair Ella with the industry leading Cygnus Technologies 3G CHO antibodies to bring you superior assay sensitivity and data reproducibility throughout the manufacturing process.
